155 related articles for article (PubMed ID: 11749692)
1. p53 and H-ras mutations and microsatellite instability in renal pelvic carcinomas of NON / Shi mice treated with N-butyl-N-(4-hydroxybutyl)-nitrosamine: different genetic alteration from urinary bladder carcinoma.
Gen H; Yamamoto S; Morimura K; Min W; Mitsuhashi M; Murai T; Mori S; Hosono M; Oohara T; Makino S; Wanibuchi H; Fukushima S
Jpn J Cancer Res; 2001 Dec; 92(12):1278-83. PubMed ID: 11749692
[TBL] [Abstract][Full Text] [Related]
2. Frequent mutations of the p53 gene and infrequent H- and K-ras mutations in urinary bladder carcinomas of NON/Shi mice treated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
Yamamoto S; Masui T; Murai T; Mori S; Oohara T; Makino S; Fukushima S; Tatematsu M
Carcinogenesis; 1995 Oct; 16(10):2363-8. PubMed ID: 7586136
[TBL] [Abstract][Full Text] [Related]
3. Genetic instability and p53 mutations in metastatic foci of mouse urinary bladder carcinomas induced by N-butyl-N-(4-hydroxybutyl)nitrosamine.
Yamamoto S; Chen T; Murai T; Mori S; Morimura K; Oohara T; Makino S; Tatematsu M; Wanibuchi H; Fukushima S
Carcinogenesis; 1997 Oct; 18(10):1877-82. PubMed ID: 9363994
[TBL] [Abstract][Full Text] [Related]
4. Infrequent involvement of microsatellite instability in urinary bladder carcinomas of the NON/Shi mouse treated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
Chen T; Yamamoto S; Gen H; Murai T; Mori S; Oohara T; Makino S; Wanibuchi H; Fukushima S
Cancer Lett; 1998 Jan; 123(1):41-5. PubMed ID: 9461016
[TBL] [Abstract][Full Text] [Related]
5. LOH and mutational analysis of p53 alleles in mouse urinary bladder carcinomas induced by N-butyl-N-(4-hydroxybutyl) nitrosamine.
Morimura K; Yamamoto S; Murai T; Mori S; Chen TX; Wanibuchi H; Fukushima S
Carcinogenesis; 1999 Apr; 20(4):715-8. PubMed ID: 10223204
[TBL] [Abstract][Full Text] [Related]
6. p53 mutations in transitional cell carcinomas of the urinary bladder in rats treated with N-butyl-N-(4-hydroxybutyl)-nitrosamine.
Masui T; Dong Y; Yamamoto S; Takada N; Nakanishi H; Inada K; Fukushima S; Tatematsu M
Cancer Lett; 1996 Jul; 105(1):105-12. PubMed ID: 8689624
[TBL] [Abstract][Full Text] [Related]
7. p53 mutations in early neoplastic lesions of the urinary bladder in rats treated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
Masui T; Don I; Takada N; Ogawa K; Shirai T; Fukushima S
Carcinogenesis; 1994 Oct; 15(10):2379-81. PubMed ID: 7955081
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of urinary bladder carcinogenesis in nullizygous p53-deficient mice by N-butyl-N-(4-hydroxybutyl)nitrosamine.
Yamamoto S; Min W; Lee CC; Salim EI; Wanibuchi H; Sukata T; Fukushima S
Cancer Lett; 1999 Jan; 135(2):137-44. PubMed ID: 10096421
[TBL] [Abstract][Full Text] [Related]
9. Clonal analysis of urothelial carcinomas in C3H/HeN<-->BALB/c chimeric mice treated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
Yamamoto S; Tatematsu M; Yamamoto M; Fukami H; Fukushima S
Carcinogenesis; 1998 May; 19(5):855-60. PubMed ID: 9635874
[TBL] [Abstract][Full Text] [Related]
10. Absence of ras oncogene activation in rat urinary bladder carcinomas induced by N-methyl-N-nitrosourea or N-butyl-N-(4-hydroxybutyl)nitrosamine.
Masui T; Mann AM; Macatee TL; Okamura T; Garland EM; Smith RA; Cohen SM
Carcinogenesis; 1992 Dec; 13(12):2281-5. PubMed ID: 1473235
[TBL] [Abstract][Full Text] [Related]
11. High susceptibility of p53(+/-) knockout mice in N-butyl-N-(4-hydroxybutyl)nitrosamine urinary bladder carcinogenesis and lack of frequent mutation in residual allele.
Ozaki K; Sukata T; Yamamoto S; Uwagawa S; Seki T; Kawasaki H; Yoshitake A; Wanibuchi H; Koide A; Mori Y; Fukushima S
Cancer Res; 1998 Sep; 58(17):3806-11. PubMed ID: 9731488
[TBL] [Abstract][Full Text] [Related]
12. DNA methylation adduct formation and H-ras gene mutations in progression of N-butyl-N-(4-hydroxybutyl)nitrosamine-induced bladder tumors caused by a single exposure to N-methyl-N-nitrosourea.
Shibata MA; Shirai T; Ogawa K; Takahashi S; Wild CP; Montesano R; Tsuda H; Ito N
Carcinogenesis; 1994 Dec; 15(12):2965-8. PubMed ID: 8001265
[TBL] [Abstract][Full Text] [Related]
13. Bracken fern-induced malignant tumors in rats: absence of mutations in p53, H-ras and K-ras and no microsatellite instability.
Freitas RN; Brasileiro-Filho G; Silva ME; Pena SD
Mutat Res; 2002 Feb; 499(2):189-96. PubMed ID: 11827712
[TBL] [Abstract][Full Text] [Related]
14. Transgenic rats carrying copies of the human c-Ha-ras proto-oncogene exhibit enhanced susceptibility to N-butyl-N-(4-hydroxybutyl)nitrosamine bladder carcinogenesis.
Ota T; Asamoto M; Toriyama-Baba H; Yamamoto F; Matsuoka Y; Ochiya T; Sekiya T; Terada M; Akaza H; Tsuda H
Carcinogenesis; 2000 Jul; 21(7):1391-6. PubMed ID: 10874018
[TBL] [Abstract][Full Text] [Related]
15. Renal pelvic carcinoma which shows metastatic potential to distant organs, induced by N-butyl-N-(4-hydroxybutyl)nitrosamine in NON/Shi mice.
Murai T; Mori S; Hosono M; Takeuchi Y; Ohara T; Makino S; Takeda R; Hayashi Y; Fukushima S
Jpn J Cancer Res; 1991 Dec; 82(12):1371-7. PubMed ID: 1778760
[TBL] [Abstract][Full Text] [Related]
16. Possible rare involvement of O6-methylguanine formation as a significant mutational factor in mouse urinary bladder carcinogenesis models.
Chen T; Yamamoto S; Kitano M; Murai T; Wanibuchi H; Matsukuma S; Nakatsuru Y; Ishikawa T; Fukushima S
Teratog Carcinog Mutagen; 1998; 18(3):101-10. PubMed ID: 9728794
[TBL] [Abstract][Full Text] [Related]
17. Lack of involvement of p53 gene mutations in N-methyl-N-nitrosourea-induced bladder tumor progression in N-butyl-N-(4-hydroxybutyl)nitrosamine-treated rats and no suppression by indomethacin.
Ozaki M; Shibata MA; Takahashi S; Orita SI; Kawabe M; Shirai T
Cancer Lett; 1997 May; 115(2):249-55. PubMed ID: 9149132
[TBL] [Abstract][Full Text] [Related]
18. H-ras activation and ras p21 expression in bladder tumors induced in F344/NCr rats by N-butyl-N-(4-hydroxybutyl)nitrosamine.
Enomoto T; Ward JM; Perantoni AO
Carcinogenesis; 1990 Dec; 11(12):2233-8. PubMed ID: 2265474
[TBL] [Abstract][Full Text] [Related]
19. Alterations of the K-ras and p53 genes and microsatellite instability in sporadic colorectal carcinomas.
Hasegawa A; Fukushima T; Mashiko M; Nakano K; Suzuki S; Endo Y; Ohki S; Hatakeyama Y; Koyama Y; Inoue N; Takebayashi Y; Sekikawa K; Takenoshita S
Anticancer Res; 2004; 24(3b):2047-52. PubMed ID: 15274399
[TBL] [Abstract][Full Text] [Related]
20. Absence of FGFR3 mutations in urinary bladder tumours of rats and mice treated with N-butyl-N-(-4-hydroxybutyl)nitrosamine.
Dunois-Lardé C; Levrel O; Brams A; Thiery JP; Radvanyi F
Mol Carcinog; 2005 Mar; 42(3):142-9. PubMed ID: 15690367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
